Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells

Journal of Gene Medicine

Volumn 5, Issue 6, 2003, Pages 483-492

  Gomez Trevino A ^a   Castel, S ^a   Lopez Iglesias C ^a   Cortadellas, N ^a   Comas Riu, J ^a   Mercade E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bystander effect; Cell membrane; Cytotoxicity; Fusogenic protein; Paramyxovirus; SV5; Syncytia; Tumor cell

Indexed keywords

GANCICLOVIR; PROTEIN PRECURSOR; PROTEINASE; THYMIDINE KINASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS FUSION PROTEIN;

ARTICLE; BYSTANDER EFFECT; CELL DEATH; CELL FUSION; CELL MEMBRANE; CELL NUCLEUS; CELL STRUCTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENETIC TRANSDUCTION; GLYCOPROTEIN SYNTHESIS; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN PARAINFLUENZA VIRUS 5; SUICIDE GENE THERAPY; SYNCYTIUM; TUMOR CELL; ADENOVIRUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GIANT CELL; IMMUNOELECTRON MICROSCOPY; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOVIRIDAE; BYSTANDER EFFECT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, VIRAL; GIANT CELLS; HUMANS; MICROSCOPY, IMMUNOELECTRON; NEOPLASMS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; VIRAL FUSION PROTEINS;

EID: 1542752193     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.371     Document Type: Article

References (42)

1. Deng R, Wang Z, Mirza AM, Iorio RM. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 1995; 209: 457-469.
2. Horvath CM, Paterson RG, Shaughnessy MA, Wood R, Lamb RA. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol 1992; 66: 4564-4569.
3. Hu X, Ray R, Compans RW. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol 1992; 66: 1528-1534.
4. Tanabayashi K, Takeuchi K, Okazaki K, Hishiyama M, Yamada A. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology 1992; 187: 801-804.
5. Tong S, Compans RW. Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins. J Gen Virol 1999; 80: 107-115.
6. Wild TF, Malvoisin E, Buckland R. Measles virus: both the hemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 1991; 72: 439-442.
7. Klenk HD, Garten W. Activation cleavage of viral spike proteins by host proteases. In Cellular Receptors for Animal Viruses Wimmer E (ed.). NT: Cold Spring Harbor, 1994; 241-280.
8. Lamb RA, Kolakofsky D. Paramyxoviridae: the viruses and their replication. In Fields Virology, Fields BN, Knipe DM, Howley PM (eds). Lippincot-Raven Publishers: Philadelphia, 1996.
9. Martin I, Ruysschaert JM. Common properties of fusion peptides from diverse systems.Biosci Reports 2000; 20: 483-500.
10. LeDuc DL, Shin Y-K. Insights into a structured-based mechanisms of viral membrane fusion. Biosci Reports 2000; 20: 557-570.
11. Melikyan GB, Chernomordik LV. Membrane rearrangements in fusion mediated by viral proteins. Trends Microbiol 1997; 5: 349-355.
12. Peuvot J, Schanck A, Lins L, Brasseurs R. Are the fusion processes involved in birth, life and death of the cell depending on tilted insertion of peptides into membranes? J Theor Biol 1999; 198: 173-181.
13. Skehel JJ, Wiley DC. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell 1998; 95: 871-874.
14. Lamb RA. Paramyxovirus fusion: a hypothesis for changes. Virology 1993; 197: 1-11.
15. Dzau VJ, Mann MJ, Morishita R, Kaneda Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Natl Acad Sci USA 1996; 93: 11 421-11 425.
16. Bateman A, Bullough F, Murphy S, et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 2000; 60: 1492-1497.
17. Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy. Cancer Res 2000; 60: 6396-6402.
18. Galanis E, Bateman A, Johnson K, et al. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgene in gliomas. Hum Gene Ther 2001; 12: 811-821.
19. Gómez-Navarro J, Curiel DT, Douglas JT. Gene therapy for cancer. Eur J Cancer 1999; 35: 867-885.
20. Vile RG, Russell SJ, Lemoin NR. Cancer gene therapy: hard lessons and new courses. Gene Ther 2000; 7: 2-8.
21. Baker K, Dutch RE, Lamb RA, Jardetzky TS. Stractural basis for paramyxovirus-mediated membrane fusion. Mol Cell 1999; 3: 309-319.
22. Becker TC, Noel RJ, Coats WS, et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 1994; 5: 161-189.
23. Randall RE, Young DF, Goswami KKA, Russell WC. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolated. J Gen Virol 1987; 68: 2769-2789.
24. Frey S, Marsh M, Gunther S, et al. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type I. J Virol 1995; 69: 1462-1472.
25. Liou W, Geuze HJ, Slot JW. Improving stractural integrity of cryosections for immunogold labeling. Histochem Cell Biol 1996; 106: 41-58.
26. Raposo G, Kleijmeer MJ, Posthuma G, Slot JW, Geuze HJ. Immunolabeling of ultrathin cryosections: application in immunology. In Handbook of Experimental Immunology, vol. 4, Herzenberg LA, Weir D, Blackwell C (eds). Blackwell Science: Cambridge, MA, 1997; 1-11.
27. Russell SJ. Replicating vectors for gene therapy of cancer: risks, limitations and prospects. Eur J Cancer 1994; 30A: 1165-1171.
28. Dutch RE, Jardetzky TS, Lamb RA. Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Reports 2000; 20: 597-612.
29. Li H, Haviv YS, Derdeyn CA, et al. Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo synthesized viras particles. Hum Gene Ther 2001; 12: 2155-2165.
30. Kemble GW, Danieli T, White JM. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 1994; 76: 383-391.
31. Kinnunen PKJ, Holopainen JM. Mechanisms of initiation of membrane fusion: role of lipids. Biosci Reports 2000; 20: 465-482.
32. Epand RM. Lipid polymorphism and protein lipid interactions. Biochim Biophys Acta 1998; 1376: 353-368.
33. Kraijtzer JAW, Liskamp RMJ, de Kruijff B, Killian A. Sensitivity of single membrane-spanning R-helical peptides to hydrophobic mismatch with a lipid bilayer: effects on backbone structure, orientation and extent of membrane incorporation.Biochemistry 2001; 40: 5000-5010.
34. Nir S, Nieva JL. Interactions of peptides with liposomes: pore formation and fusion, Prog Lipid Res 2000; 39: 181-206.
35. Rinia A, Kik RA, Demel RA, et al. Visualization of highly ordered striated domains induced by transmembrane peptides in supported phosphatidylcholine bilayers. Biochemistry 2000; 39 5852-5858.
36. Kolesnitchenko V, Wahl LM, Tian H, et al. Human immunodeficiency viras 1 envelope-initiated G2-phase programed cell death. Proc Natl Acad Sci U S A 1995; 92: 11 889-11 893.
37. Paterson RG, Lamb RA, Moss B, Murphy BR. Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus Simian virus 5 in inducing protective immunity. J Virol 1987; 61 1972-1977.
38. Mbaky M, Sirois F, Yao J, Seidah NG, Chretien M. Comparative analysis of expression of the protein convertases furin, PACE4, PC1 and PC2, in human lung tumours. Br J Cancer 1997; 75: 1509-1514.
39. Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M, Shiu R. Pro-protein convertase gene expression in human breast cancer. Int J Cancer 1997; 71: 966-971.
40. Schalke JA, Roebroek JM, Oomen PPCA, et al. Fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. J Clin Invest 1987; 80: 1545-1549.
41. Nilson BH, Morling FJ, Cosset FL, Russell SJ. Targeting of retroviral vectors through protease-substrate interactions. Gene Ther 1996; 3: 280-286.
42. Peng KW, Vile R, Cosset FL, Russell SJ. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors. Gene Ther 1999; 6: 1552-1557.